Court Place Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-601
Closed -$234K 150
2025
Q2
$234K Sell
601
-16
-3% -$6.44K 0.07% 135
2025
Q1
$268K Sell
617
-50
-7% -$20.1K 0.09% 128
2024
Q4
$246K Hold
667
0.08% 133
2024
Q3
$347K Hold
667
0.1% 124
2024
Q2
$361K Hold
667
0.11% 119
2024
Q1
$346K Hold
667
0.11% 119
2023
Q4
$315K Hold
667
0.1% 126
2023
Q3
$290K Hold
667
0.1% 126
2023
Q2
$296K Hold
667
0.1% 130
2023
Q1
$307K Hold
667
0.11% 129
2022
Q4
$342K Hold
667
0.12% 123
2022
Q3
$303K Hold
667
0.12% 125
2022
Q2
$322K Hold
667
0.12% 127
2022
Q1
$328K Hold
667
0.11% 137
2021
Q4
$309K Hold
667
0.09% 152
2021
Q3
$249K Hold
667
0.07% 160
2021
Q2
$255K Hold
667
0.07% 164
2021
Q1
$239K Hold
667
0.07% 165
2020
Q4
$214K Buy
+667
New +$205K 0.07% 162
2020
Q1
Sell
-676
Closed -$204K 166
2019
Q4
$204K Buy
+676
New +$186K 0.07% 175

Other funds holding ELV

Court Place Advisors's ELV Position: Q3 2025 in Review

Court Place Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 601 shares — an estimated $234K sold.

Court Place Advisors first reported a position in ELV in Q4 2019 and held it in 20 quarters. The position peaked at $361K in Q2 2024. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Court Place Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Court Place Advisors sold 601 Elevance Health shares in Q3 2025, an estimated $234K.
  • Court Place Advisors first reported a position in Elevance Health in Q4 2019 and held it in 20 quarters.
  • Court Place Advisors's Elevance Health position peaked at $361K in Q2 2024.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Court Place Advisors's 13F filing for Q3 2025, filed 25 Nov 2025.